Rationale, aims, and objectives: Children with cerebral palsy (CP) can show an increase in gross motor function until the age of 9 to 10 years under the standard of care. Additionally, the motor development can have large individual fluctuations. Therefore, in clinical setting, it is not trivial to estimate the effect of an additional therapeutic intervention at this age interval. The study aim was to develop a method which allows quantification of the gross motor function changes over 6 months of the individual child with CP. Results: In total, the GMFM-66 data of 919 children before starting the rehabilitation program were available (age 6.49 ± 2.49 years, GMFCS-level I-V). For 515 study participants (6.76 ± 2.30 years, GMFCS-level I-V), data were also available at the start and the end of a 6-month observational phase.
| INTRODUCTION
Cerebral palsy (CP) is the most common cause of physical disability in early childhood and is defined as a group of permanent, but not unchanging, disorders of movement, and/or posture due to a non-progressive lesion in the developing brain. 1 According to the Surveillance of Cerebral Palsy in Europe, the prevalence is 2 to 3 per 1000 live births. 1 The motor impairment results in weakness, secondary conditions like muscle atrophy, contractures and bone deformities, dependence on external support in daily life, and lifelong high cost of health care. 2 Globally, cost-effectiveness is important in the health care system, and proof of efficacy of interventions is of high priority; there is a need to identify responders and non-responders to interventions in order to tailor targeted-therapy programs. 3 In the last decade, many studies have been published on the therapeutic effect of different interventions for CP. Motor function is the most common outcome parameter. 4 The Gross Motor Function Measure (GMFM-66) is the most commonly used measure for general motor function in children and adolescents with CP. 5 An increase is generally interpreted as a response to intervention. But an increase in the GMFM-66 is also expected receiving only standard of care
(especially in young children). 6 Thus, it is unclear how much of an increase on the GMFM-66 is due to intervention or expected progression. In the present study, expected progression of GMFM-66 was defined as the development of GMFM-66 in a child, who received only the typical standard of care in a certain health system (in the present study: German health care system, usually 2-3 times 30-40 minutes physiotherapy per week) without participating in an additional intensive rehabilitation program.
Some attempts have been made to solve this problem. The first was introduced by the developers of the GMFM-66 in 2008. 7 They calculated GMFM-66 reference centiles for each level of the Gross Motor Function Classification System (GMFCS). They recommended using centiles to measure the effect of interventions. Additionally, they calculated probabilities for the change of centiles based on longitudinal data (median time for re-assessment 1 year). With their method, this probability can only be roughly estimated. The following, real case study illustrates the method of Hanna et al 7 :
A girl with bilateral spastic CP GMFCS level I started the training with a GMFM-66 score of 85.2 at the age of 6 years and 8 months and reached a score of 89.7 after 6 months. Is this GMFM-66 increase to be interpreted as a therapeutic effect or does it reflect the expected progression of GMFM-66 at this age under standard of care?
Using the reference centiles of Hanna et al 7 following can be calculated:
• At M0: Z-score of GMFM-66: -0.17 and centile of GMFM-66:
43.3
• At M6: Z-score of GMFM-66: 0.26 and centile of GMFM-66: 60.3
According to Hanna et al, 7 the probability of a centile change between two assessments 1 year apart for children with GMFCS-level I is
• 25% more than 10.5 centile increase
• 10% for more than 20.0 centile increase.
The reported girl had a centile increase of 17.0 over 6 months. With the method of Hanna et al, 7 it is not possible to specify exactly the probability of a centile increase of 17.0 (or more) over 6 months. It can be supposed, that the probability lies between 10% and 25%.
In the Discussion, the same case study will evaluated again with the method presented in this study.
Minimal clinically important differences (MCIDs) have been introduced for the GMFM-66 in 2008 to detect meaningful changes based on Cohen's d effect size, but the age of the children was not considered. 8 Recently, Marois et al proposed the GMFM Evolution Ratio. 9 Here, the GMFM-66 increase can be compared with the predicted normal development but also based on a group of children and not on the individual.
The aim of this study was 2 | METHODS
| Study population
The present study was a single center retrospective analysis of pro- The inclusion criteria were main diagnosis of CP and age between 2 and 11 years. In total, 1188 complete GMFM-66 assessments were performed in children with CP at M0 (Figure 2 ). The age range was chosen up to 11 years because previous studies have shown that gross motor function of children with CP assessed by the GMFM-66 plateaus at 9 to 10 years of age. 6, 7, 10 Exclusion criteria were specific genetic syndromes and severe chronic diseases (seven patients were excluded) or age exceeding the defined age range for inclusion (262 excluded). In total, 919 GMFM-66 measurements at M0 were eligible for the calculation of reference centiles.
Complete GMFM-66 follow-up measurements were available for 515 children at M6 and M12. The development of the GMFM-66 scores between M6 and M12 was regarded as the expected progression of the GMFM-66, because in this time interval the children got only the standard of care of Germany. To prove this assumption, the effect size (SRM) of the GMFM-66 change between M6 and M12 using the generated GMFM-66 centiles was calculated. The GMFM-66 Z-score at M6 and M12 were used to estimate the variability of the expected GMFM-66 development over 6 months. Simplified, the correlation coefficient of the GMFM-66 Z-scores at M6 and M12 can be used to calculate the distribution of a centile change (calculation of correlation coefficients r, see Supporting Information eMethods).
After provision of written informed consent from the legal representative of the child, clinical data were stored in a prospective single center patient registry. The responsible Ethics Committee approved this registry.
| Motor function
The GMFM-66 is an observational clinical measure to evaluate gross motor function in children with CP. 11 It consists of 66 motor tasks (items), was validated, and was commonly used to quantify motor skills in children with CP. The results of the individual items were analysed using the Gross Motor Ability Estimator Scoring Software (CanChild,
McMaster University, Ontario, Canada). Measurements had only been regarded as complete when at least 23 items (of 66) were scored.
Avery et al proposed that 13 completed items would be sufficient, but they emphasized that more items tested correlate with higher accuracy.
11
The Gross Motor Function Classification System (GMFCS) consists of a 5-point ordinal scale, designated as I to V. 12 Children with GMFCS-level I and II can walk without support or with limitations, respectively; children with level III and IV can only walk using handheld mobility devices or powered mobility; children classified as level V are only passively transported in a manual wheelchair and show deficits in head and trunk control. 12 
| Reference centile estimation
The LMS (lambda-mu-sigma) method, developed by Cole and Green, was used to generate age-related reference centile curves for the GMFM-66 score. 13 The detailed description of the centile generation is shown in the Supporting Information (eMethods).
One reference centile curve was generated with all GMFM-66 scores at M0 (method A). Next, the children were classified according to their GMFCS-level. A reference centile curve for GMFM-66 levels at M0 was generated for each GMFCS-level (method B).
The goodness of fit of method A and B were calculated as follows:
1. The GMFM-66 Z-scores at M6 was assessed by method A and B.
2. Thus, the gross motor development between M6 and M12 was regarded as expected progression, and the reference centile should represent the expected progression; the GMFM-66 Zscores at M6 and M12 were anticipated to be the same.
3. With the GMFM-66 Z-scores at M6, predicted GMFM-66 score at M12 was estimated for both methods.
4. The better a model can predict the expected GMFM-66 progression, the lower the difference between the measured GMFM-66 score at M12 and predicted GMFM-66 at M12 score will be. Therefore, the square sum of the GMFM-66 score differences was calculated for both methods separately for each GMFCS-level and was then compared with each other. The method with the lowest square sum has a better goodness of 
| Effect size estimation and minimal clinical important difference
The effect size quantifies the size of difference between two groups in a measure, for example pre-intervention and post-intervention. 
where change score is the difference of the measures between two time points t 2 and t 1 :
This effect size was renamed by Liang et al as standardized response mean (SRM), and Cohen's guidelines for interpretation of effect size can be applied to SRM. 15 If the measure Z has a standard normal distribution, the effect size can be interpreted as a Z-score. 16 Therefore, SRM (for a group) is equal to the Z-score of centile change (for an individual) given in formula (5) in eMethods. The proof is shown in eMethods (Supporting Information).
The MCID was defined as the minimal amount of change that had significance to the patient or the practitioner. 17 Often, a distributionbased approach was used to determine the MCID. Based on the statistical characteristics of the sample, the probability that the change had occurred by chance was estimated. According to Portney and Watkins, the mean change score needed to obtain a medium (0.5 to 0.8) or large (≥0.8) effect size was clinically meaningful. 3 | RESULTS
| Study population
At M0, 919 participants fulfilled the inclusion criteria. Of these, 384
(41.8%) participants were female, the mean age was 6.49 ± 2.49 years, the mean height was 112.5 ± 15.5 cm, and the mean BMI was 15.3 ± 2.5 kg/m 2 ( Table 1) . Most participants were classified as bilateral spastic CP (73.1%) followed by mixed type CP (9.6%), unilateral spastic CP (7.7%), dyskinetic CP (6.9%), and ataxic CP (2.7%). The distribution of the GMFCS-levels was as follows: GMFCS-level I (7.4%), II (18.2%), III (37.6%), IV (31.0%), and V (5.8%). Of the 919 participants with a complete GMFM-66 measurement at M0, 515 also had a complete GMFM-66 measurement at M6 and M12. The characteristics of the two groups did not differ significantly regarding GMFCS levels and type of CP (Table 1) .
3.2 | Reference centile estimation and evaluation of the goodness of fit for method A and B Table 2 depicts the square sum of the differences of measured and predicted GMFM-66 scores at M12 according to method A and B. Method A includes one reference centile for all GMFCS levels.
Method B includes five distinct reference centiles for each GMFCS level.
One reference centile for all GMFCS levels (method A) had lower square sums than five separate reference centiles (method B) for GMFCS-level III and IV; for GMFCS-level I and V, method B was better, and for GMFCS-level II both methods had a similar goodness of fit.
In summary, the goodness of fit was at least, relatively similar in both methods, but the method B is much more complex. So, as is usual in development of theoretical models, the simpler method A was preferred ("occam's razor"). Figure 3 depicts the reference centile curves generated by method A; the tabulated reference centile is given in Table 3 .
| Correlation coefficient r estimation
Using the generated GMFM-66 centiles (method A), the GMFM-66 Zscore at M6 and M12 were calculated for 515 children with CP. The Z-scores were significantly (P = .025) different between M6 and M12, but SRM indicated a negligible effect size (d = −0.098). With a sufficiently large sample size, even the smallest difference between two groups becomes statistically significant at some point. Therefore, the term effect size was introduced in the statistics to assess the relevance of the difference between two groups. The fact that the GMFM-66 in 515 children were not relevantly different between M6 and M12 (effect size was negligible) indicated that the mean development of the GMFM-66 between M6 and M12 was comparable to the prediction of the presented reference centiles. Because the reference centiles describe the development under the standard of care, the interval between M6 and M12 can be assumed to be the expected progression of GMFM-66 under standard of care (observation phase).
The bold dashed line in the lower third of Figure 3 represents the SD of the difference of two GMFM-66 Z-scores measured 6 months Table 4 . For clinical use, the SD should be evaluated at the first (primary) measure.
| Comparison with published data
To compare our reference centiles with the original reference curves of Hanna et al, the P50 centile of each GMFCS-level (I to V) were superimposed with our centiles ( Figure 4A ). 7 The depicted centiles were selected to trace the curves of Hanna et al. 7 Smits et al recently reported the GMFM-66 development in Dutch children and young adults with CP. 10 They used longitudinal data of 423 individuals and developed the course of the predicted value for GMFM-66 score for each GMFCS-level using a nonlinear mixed-effect model. Figure 4B shows our reference centile curves superimposed with the results of Smits et al. The depicted centiles were selected to trace the curves of Smits et al. 10 
| Application of the proposed method
In order to demonstrate the usefulness of the proposed method for quantifying the progress of the GMFM-66 score between two time points in the individual patient with CP, a case study will be presented in the Discussion. In addition, the presented rehabilitation program will be evaluated using the presented reference centiles for the GMFM-66, and the participants will be classified in responder and nonresponder (Table 5 , details see Discussion).
| DISCUSSION
To predict the expected progression of GMFM-66, we proposed using one reference centile for all GMFCS-levels instead of five separate reference centiles. Our analysis had shown that the prediction of the GMFM-66 was not better with distinct reference centiles for each GMFCS-level (Table 2 ). In concordance, Marois et al recently proposed b Chi-square test/fisher exact test was used in nominal factors; otherwise, Kruskal-Wallis test was used.
the training with a GMFM-66 score of 85.2 at the age of 6 years and 8 months and reached a score of 89.7 after 6 months. Using the reference centiles of Hanna et al, it can be supposed, that the probability for this centile change lies between 10% and 25% (for details see Introduction).
With our method, the following can be calculated: Using our ref- The probability of the GMFM-66 centile increase can be used to answer the clinical question whether the observed centile increase can be interpreted as a therapeutic effect: The lower the probability of the centile increase in expected progression of GMFM-66, the more likely a therapeutic effect is present.
Additionally, with the proposed method, there is an easier way to answer the above question: Because the Z-score of centile change is equal to the value of the SRM (defined by formula (5) When comparing our reference centiles to the GMFM-66 progression curves of Smits et al 10 in Dutch children, they show similar progression, although they were calculated from different data (longitudinal versus cross-sectional) and different models (nonlinear mixed effect model versus the LMS-method). This indicates that our reference centile truly reflects the expected GMFM-66 progression under standard of care. In contrast to the centiles by Hanna et al, 22 we could only find a very small decline of the GMFM-66 by approximately 1 point (especially in the higher GMFCS-levels and age 8.5-10.0 years).
FIGURE 5
Case study. The figure illustrates the usage of the reference centiles. First, the two GMFM-66 scores are entered (the two upper crosses, age 1 = 6y 8mo, age 2 = 7y 2mo) and the corresponding Z-scores are easily read (Z 1 = 2.1, Z 2 = 2.3). Then, the agedependent standard deviation (SD) of the centile change is determined by using the dashed curve and the age of the child at the first GMFM-66 measurement (lower cross, SD = 0.19). Then, with the simple formula Z 2 −Z 1 SD , the Z-score for the centile change can be calculated, which corresponds to the individual effect size (= 1.04)
Hanna et al reported a decline of 4.7 to 7.8 points in the GMFCSlevels III to V. 22 Smits et al 10 reported no decline of the GFMM-66 in their data. The reason for the differences between the study of Hanna et al and our study might be differences in standard of care, which may be more similar between Germany and the Netherlands than that in Canada.
To demonstrate the advantage of the proposed method for researchers, we analysed the effect of the rehabilitation program on gross motor function in our study population. The change score of the 515 children with CP was calculated as
Change score n = GMFM-66 Z-score n at M6 -GMFM-66 Zscore n at M0, for n = 1-515 Z-scores were calculated with the reference centile in Figure 3 . Thus, mean change score was 0.152 SD of change score was 0.207 P-value was P < 0.001 (Wilcoxon signed rank test)
According to formula (6), the SRM was 0.723 (95%CI: 0.608-0.861).
The effect of the rehabilitation program could also be estimated (Table 5) . Less affected children (GMFCS-level I and II) tend to benefit more than children with GMFCS-level III-V, but not significantly. The results of this observational study can only be used to generate hypothesis of the effectiveness. Randomized, controlled studies are needed to prove the generated hypothesis.
But the main point is that by applying the proposed method, the results of a study can be used to identify participants' characteristics that influence intervention outcome more accurately by estimating the individual effect size (regarding GMFM-66). Therefore, it might be possible to answer the question of what works best and for whom in the future. 
| Study limitations
Limitations of this study include selection bias because our reference centile is based on data of the rehabilitation program, which treats children with motor limitations. Therefore, relatively few children with CP GMFCS-level I are represented in this cohort. However, children with CP GMFCS-level I cannot be well assessed longitudinally by the GMFM-66, because they show a ceiling effect as indicated by Hanna et al, presenting a cropped centile for GMFCS-level I at 100%. 7 We only calculated the reference centiles until the age of 12 years, but according to other publications on this topic 10 and our own data, the GMFM-66 and the SD of the difference plateau for children older than 12 years. Another limitation is that only 6-month time periods can be evaluated for Z-scores, because the SD of the GMFM-66 difference depends on age as well as on time between the measurements. Therefore, for other time periods, we can only estimate whether the GMFM-66 score is equal, above, or below the expected development.
Further studies should calculate the SD of GMFM-66 differences for a 1-year period, for example. This would be particularly important when assessing the effect of orthopaedic surgery on motor function, because 1 year is usually the time period for recovery.
| CONCLUSIONS
The presented method helps to guide the clinician to track the individual patient's gross motor development and assess the additional effect of an additionally applied intervention while taking into account the expected progression of gross motor function under standard of care.
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